Published in Am J Public Health on March 01, 1986
Effects of Eyjafjallajökull volcanic ash on innate immune system responses and bacterial growth in vitro. Environ Health Perspect (2013) 1.47
A retrospective study on acute health effects due to volcanic ash exposure during the eruption of Mount Etna (Sicily) in 2002. Multidiscip Respir Med (2013) 0.99
GRACE: public health recovery methods following an environmental disaster. Arch Environ Occup Health (2010) 0.98
Emergency room visits for respiratory conditions in children increased after Guagua Pichincha volcanic eruptions in April 2000 in Quito, Ecuador observational study: time series analysis. Environ Health (2007) 0.93
Assessment of the exposure of islanders to ash from the Soufriere Hills volcano, Montserrat, British West Indies. Occup Environ Med (2002) 0.88
The structure of volcanic cristobalite in relation to its toxicity; relevance for the variable crystalline silica hazard. Part Fibre Toxicol (2012) 0.80
Effects of fresh and aged vehicular exhaust emissions on breathing pattern and cellular responses--pilot single vehicle study. Inhal Toxicol (2012) 0.79
Pulmonary epithelial response in the rat lung to instilled Montserrat respirable dusts and their major mineral components. Occup Environ Med (2002) 0.77
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer (1976) 6.48
Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med (1980) 4.14
Defense mechanisms of the respiratory membrane. Am Rev Respir Dis (1977) 2.77
Silicosis. Am Rev Respir Dis (1976) 2.38
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res (1976) 2.31
Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis (1981) 2.23
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Acute effects of breathing inert dust particles and of carbachol aerosol on the mechanical characteristics of the lungs in man; changes in response after inhaling sympathomimetic aerosols. J Clin Invest (1958) 1.85
Quartz hemolysis as related to its surface functionalities. Environ Res (1981) 1.47
Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis (1984) 1.45
Interaction of crocidolite asbestos with hamster respiratory mucosa in organ culture. Lab Invest (1977) 1.43
Health implications of the Mount St. Helen's eruption: laboratory investigations. Ann Occup Hyg (1982) 1.31
Metal toxicity for rabbit alveolar macrophages in vitro. Environ Res (1975) 1.24
The distribution of dust in the rat lung following administration by inhalation and by single intratracheal instillation. Environ Res (1985) 1.23
Is volcanic ash a pneumoconiosis risk? Nature (1981) 1.20
A comparison of the relative rates of hemolysis induced by various fibrogenic and non-fibrogenic particles with washed rat erythrocytes in vitro. Am Ind Hyg Assoc J (1975) 1.01
Comparative effects of inhaled volcanic ash and quartz in rats. Am Rev Respir Dis (1983) 0.98
Early damage indicators in the lung. III. Biochemical and cytological response of the lung to inhaled metals salts. Toxicol Appl Pharmacol (1979) 0.95
Effect of alveolar lining material-coated silica on rat alveolar macrophages. Environ Health Perspect (1983) 0.95
Depression of viral interferon induction in cell monolayers by asbestos fibers. Environ Res (1976) 0.94
Early damage indicators in the lungs. IV. Biochemical and cytologic response of the lung to lavage with metal salts. Toxicol Appl Pharmacol (1979) 0.93
Inhalation studies of Mt. St. Helens volcanic ash in animals. II. Lung function, biochemistry, and histology. Environ Res (1985) 0.91
The pulmonary toxicity of an ash sample from the MT. St. Helens Volcano. Exp Lung Res (1981) 0.88
Pulmonary toxicity of Mount St. Helens volcanic ash. Environ Res (1982) 0.86
Experimental studies on the effects of Mt. Sakurajima volcanic ashes on the respiratory organs. Sangyo Igaku (1984) 0.86
Pulmonary reaction to metallic aluminum powders: an experimental study. Arch Environ Health (1973) 0.85
Lung changes in rats inhaling volcanic ash for one year. Am Rev Respir Dis (1983) 0.85
Pulmonary response to Mount St. Helens' volcanic ash. Environ Res (1983) 0.84
Mount St. Helens' volcanic ash: hemolytic activity. Environ Res (1983) 0.84
Volcanic ash: toxicity to isolated lung cells. J Toxicol Environ Health (1982) 0.83
Deposition and clearance following inhalation and intratracheal injection of particles. Arch Environ Health (1969) 0.83
Inhalation studies of Mt. St. Helens volcanic ash in animals: respiratory mechanics, airway reactivity and deposition. Environ Res (1985) 0.83
The comparative toxicity of volcanic ash and quartz. Effects on cells derived from the human lung. Am Rev Respir Dis (1984) 0.83
Comparative in vitro cytotoxicity of volcanic ashes from Mount St. Helens, El Chichon, and Galunggung. J Toxicol Environ Health (1984) 0.82
Effect of Mount St. Helens ash on the response of rat trachea to smooth muscle agonists. Environ Res (1981) 0.82
The influence of the size of wuartz dust particles on the reaction of lung tissue. Ann Occup Hyg (1973) 0.82
Response of hamster trachea in organ culture to Mount St. Helens volcano ash. Scan Electron Microsc (1981) 0.81
Effect of silica and volcanic ash on the content of lung alveolar and tissue phospholipids. Environ Res (1984) 0.80
The short-term effects of volcanic ash on the small airways of the respiratory system. Environ Res (1982) 0.80
Inhalation studies of Mt. St. Helens volcanic ash in animals. III. Host defense mechanisms. Environ Res (1985) 0.79
Effects of lignite fly ash particulates and soluble components on the interferon system. Environ Res (1983) 0.78
In vitro response of human pulmonary macrophages with volcanic ash: a morphological study. Exp Mol Pathol (1982) 0.77
Lung clearance of neutron-activated Mount St. Helens volcanic ash in the rat. Environ Res (1984) 0.77
Volcanic ash and human complement. Life Sci (1981) 0.77
Pulmonary toxicity of Mt. St. Helens volcanic ash. A review of experimental studies. Am Rev Respir Dis (1983) 0.76
Long-term reactivity of lung and mediastinal lymph nodes following intratracheal instillation of sandy loam soil or Mount St. Helens volcanic ash. Environ Res (1983) 0.76
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med (1989) 5.10
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood (1996) 4.65
Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia (2000) 4.42
Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest (1998) 3.85
Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature (1998) 3.02
Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci U S A (2001) 2.88
Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med (1999) 2.81
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 2.81
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest (1999) 2.67
Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol (2001) 2.66
Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.60
Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues. Br J Psychiatry (1996) 2.36
Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.33
Active anaphylaxis in IgE-deficient mice. Nature (1994) 2.32
Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med (1997) 2.26
Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol (1999) 2.25
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet (1986) 2.21
Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation (1998) 2.21
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med (1999) 2.20
Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol (2001) 2.18
Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol (2001) 2.16
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11
Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med (1997) 2.10
Reactions of nitrogen dioxide in aqueous model systems: oxidation of tyrosine units in peptides and proteins. Arch Biochem Biophys (1985) 2.08
Non-invasive measurements of breast tissue optical properties using frequency-domain photon migration. Philos Trans R Soc Lond B Biol Sci (1997) 2.05
Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med (2000) 2.04
PALB2 mutations in European familial pancreatic cancer families. Clin Genet (2010) 1.99
Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A (1997) 1.99
Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med (1994) 1.98
Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol (1994) 1.95
Evaluation of a social work service for self-poisoning patients. Br J Psychiatry (1978) 1.95
Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet (2001) 1.94
T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat Med (1997) 1.94
Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology (1999) 1.91
Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med (1996) 1.88
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest (1989) 1.88
The effects of ultrasonically-produced aerosols on airway resistance in man. Anesthesiology (1969) 1.87
Quantitative determination of trucking industry workers' exposures to diesel exhaust particles. Am Ind Hyg Assoc J (1991) 1.87
Community action for health promotion: a review of methods and outcomes 1990-1995. Am J Prev Med (1997) 1.86
Spectroscopy enhances the information content of optical mammography. J Biomed Opt (2002) 1.83
Association of low birth weight with passive smoke exposure in pregnancy. Am J Epidemiol (1986) 1.80
Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med (1991) 1.78
Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med (1999) 1.77
Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis (1989) 1.75
Variability of routine pulmonary function tests. Thorax (1975) 1.72
Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J (1987) 1.71
Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet (1995) 1.70
The bronchial circulation. Small, but a vital attribute of the lung. Am Rev Respir Dis (1987) 1.67
Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation (1997) 1.64
An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb. BMJ (2000) 1.61
Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med (1999) 1.61
Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics (2000) 1.55
Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol (1991) 1.54
Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr (1994) 1.50
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol (2000) 1.48
[A basic set of indicators for mapping migrant status. Recommendations for epidemiological practice]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2006) 1.48
The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest (1982) 1.48
Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med (1997) 1.48
Intra-ocular pressure changes using the laryngeal mask airway and tracheal tube. Anaesthesia (1991) 1.48
The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol (1987) 1.47
Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis (1984) 1.45
Three-dimensional diffuse optical mammography with ultrasound localization in a human subject. J Biomed Opt (2000) 1.45
Rapid fluorescence-based measurement of neutrophil migration in vitro. J Immunol Methods (1998) 1.44
Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr (1987) 1.44
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer (2013) 1.42
Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am J Physiol (1999) 1.42
One hundred consecutive advanced breast biopsy instrumentation procedures: complications, costs, and outcome. Ann Surg Oncol (1999) 1.39
Gamma knife radiosurgery for large vestibular schwannomas: a Canadian experience. Can J Neurol Sci (2013) 1.39
Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass. Anaesth Intensive Care (2005) 1.39
Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol (1999) 1.38
SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J Clin Invest (1999) 1.36
Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med (1980) 1.34
Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer (2000) 1.33
Mortality after esophagectomy: risk factor analysis. World J Surg (1997) 1.32
Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med (1999) 1.31
Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis (1987) 1.31
The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis (1985) 1.31
Preliminary report on hormone receptors in the human vocal fold. J Voice (2000) 1.30
Sexual behavior in pregnancy. N Engl J Med (1973) 1.29
The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J (1988) 1.29
Septic shock and acute lung injury in rabbits with peritonitis: failure of the neutrophil response to localized infection. Am J Respir Crit Care Med (2001) 1.27
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation (2000) 1.27
Well-done, grilled red meat increases the risk of colorectal adenomas. Cancer Res (1999) 1.27
Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol (1992) 1.26
Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect Immun (2001) 1.26
Comparative trial of volunteer and professional treatments of dysphasia after stroke. Br Med J (1979) 1.25
Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med (1997) 1.23
Structural requirements for ligand binding by a probable plant vacuolar sorting receptor. Plant Cell (2000) 1.23
Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol (2000) 1.23
T cell receptor alpha-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant. Int Immunol (1992) 1.22
Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest (1996) 1.22
Kinetics and mechanism of the reduction of ferricytochrome c by the superoxide anion. J Biol Chem (1982) 1.22
The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol) (2012) 1.21
A multicenter case-control study of diet and lung cancer among non-smokers. Cancer Causes Control (2000) 1.20
Predicting tumor response in patients with colorectal hepatic metastases. Ann Surg (1985) 1.20